Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07857317

Non-Contrast Versus Contrast-Enhanced MRI in Colorectal Liver Metastases

Conditions: Liver Metastases, Liver Neoplasms

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 40
Sponsor: Assiut University

Summary

This prospective study aims to compare the diagnostic performance of a non-contrast abbreviated MRI protocol with a contrast-enhanced MRI protocol for the detection and follow-up assessment of colorectal liver metastases.

Eligibility Criteria

Inclusion Criteria: * \- Histologically confirmed colorectal adenocarcinoma * One or more hepatic focal lesions known or suspected to represent colorectal liver metastases * Adequate image quality allowing reliable assessment of hepatic lesions * Patients scheduled to receive chemotherapy allowing assessment of treatment response * Patients referred for initial staging, restaging, or evaluation of treatment response * Written informed consent Exclusion Criteria: * \- Contraindications to gadolinium-based contrast administration * Incomplete MRI examinations * Inadequate image quality preventing reliable assessment * Contraindications to MRI examination

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07857317). StuddyBuddy aggregates publicly available trial information.